162 related articles for article (PubMed ID: 32087404)
1. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients.
Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
3. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
Morgan IA; Zapata LB; Curtis KM; Whiteman MK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
[TBL] [Abstract][Full Text] [Related]
4. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists.
Castleberry NM; Stark L; Schulkin J; Grossman D
Contraception; 2019 Aug; 100(2):123-127. PubMed ID: 30981843
[TBL] [Abstract][Full Text] [Related]
5. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
Davis SA; Braykov NP; Lathrop E; Haddad LB
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Uptake of Long-Acting Reversible Contraception in South Dakota Women and the Importance of Provider Education.
Weber TL; Briggs A; Hanson JD
S D Med; 2017 Nov; 70(11):493-497. PubMed ID: 29088520
[TBL] [Abstract][Full Text] [Related]
7. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement.
Thompson CM; Broecker J; Dade M
J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827
[TBL] [Abstract][Full Text] [Related]
8. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL
Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320
[TBL] [Abstract][Full Text] [Related]
9. IUD services among primary care practices in New York City.
Jacobson L; Garbers S; Helmy H; Roobol H; Kohn JE; Kavanaugh ML
Contraception; 2016 Mar; 93(3):257-62. PubMed ID: 26569447
[TBL] [Abstract][Full Text] [Related]
10. Access to long-acting reversible contraception among US publicly funded health centers.
Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S
Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581
[TBL] [Abstract][Full Text] [Related]
11. Health Care Barriers to Provision of Long-Acting Reversible Contraception in Wisconsin.
Olson EM; Kramer RD; Gibson C; Wautlet CK; Schmuhl NB; Ehrenthal DB
WMJ; 2018 Oct; 117(4):149-155. PubMed ID: 30407764
[TBL] [Abstract][Full Text] [Related]
12. Comparing methods of long-acting reversible contraception: A qualitative study of Delaware women's perceptions of intrauterine devices and the implant.
Manzer JL; Berndt VK; Bell AV
Contraception; 2022 Sep; 113():73-77. PubMed ID: 35417755
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of initiation of intrauterine devices and subdermal implants immediately after surgical abortion.
Roe AH; Fortin J; Janiak E; Maurer R; Goldberg AB
Contraception; 2019 Aug; 100(2):89-95. PubMed ID: 31082394
[TBL] [Abstract][Full Text] [Related]
14. Changes in uptake and cost of long-acting reversible contraceptive devices following the introduction of a new low-cost levonorgestrel IUD in Utah's Title X clinics: a retrospective review.
Roth LP; Sanders JN; Simmons RG; Bullock H; Jacobson E; Turok DK
Contraception; 2018 Jul; 98(1):63-68. PubMed ID: 29574095
[TBL] [Abstract][Full Text] [Related]
15. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
[TBL] [Abstract][Full Text] [Related]
16. Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception?
Rivas K; Schmuhl NB; Taboada M; Godecker A; Brown H
Contraception; 2021 Oct; 104(4):372-376. PubMed ID: 34081975
[TBL] [Abstract][Full Text] [Related]
17. Trends of Contraceptive Choices Among Young Women in Inner City Houston.
Patel PR; Abacan A; Smith PB
J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):487-490. PubMed ID: 31125608
[TBL] [Abstract][Full Text] [Related]
18. US family physicians' intrauterine and implantable contraception provision: results from a national survey.
Nisen MB; Peterson LE; Cochrane A; Rubin SE
Contraception; 2016 May; 93(5):432-7. PubMed ID: 26776938
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the provision of long-acting reversible contraception in California.
Biggs MA; Harper CC; Malvin J; Brindis CD
Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
[TBL] [Abstract][Full Text] [Related]
20. Follow-Up Care and 6-Month Continuation Rates for Long-Acting Reversible Contraceptives in Adolescents and Young Adults: A Retrospective Chart Review.
Jones AE; Kaul S; Harding J; Weldon DLM; Akers AY
J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):39-44. PubMed ID: 31513921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
